ACS Vascular Verification Program Verifies Froedtert Hospital
Froedtert & MCW Froedtert Hospital receives national verification from the American College of Surgeons Vascular Verification Program
SVS Foundation Announces Enrico Ascher Vascular Innovation Institute, Launching at VAM 2026
[Rosemont, Illinois] October 20, 2025 - The Society for Vascular Surgery (SVS) Foundation today announced the launch of the Enrico Ascher Vascular Innovation Institute, a groundbreaking initiative dedicated to advancing innovation in vascular surg
Vascular Verification Program Verifies Memorial Regional Hospital
Memorial Regional Hospital receives national verification from the American College of Surgeons Vascular Verification Program
New Clinical Practice Guideline on the Management of Intermittent Claudication
Timely update comes as September marks Peripheral Artery Disease (PAD) Awareness Month
Silent Vascular Threat: Nearly 70% of Americans Unaware of PAD – The Leading Cause of Preventable Amputations
During PAD Awareness Month, the Society for Vascular Surgery Urges Americans to Learn How to Safeguard Their Vascular Health
Society for Vascular Surgery Responds to Public Awareness of Chronic Venous Insufficiency Following President Trump’s Diagnosis
Rosemont, Ill. – July 17, 2025 — The Society for Vascular Surgery (SVS) acknowledges the increased public attention surrounding chronic venous insufficiency (CVI) following news reports of President Donald J.
Novel Bioengineered Vessel Outperforms Arteriovenous Fistula in High-Risk Patients on Hemodialysis
Findings from a phase three, randomized controlled clinical trial demonstrate the superiority of Humacyte’s Acellular Tissue Engineered Vessel (ATEV) over autologous arteriovenous fistula (AVF) in high-risk patients with end-stage kidney disease (ESKD).
New Study Finds GLP-1 Medications Decrease Risk of Major Cardiovascular Events and Amputations for Patients with Moderate Peripheral Artery Disease
A large retrospective review of over 100,000 patients found the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in moderate peripheral artery disease (PAD) is associated with a decreased rate of cardiovascular events, major limb events, and inpatient admissions.
20-Year Study Shows Strong Outcomes for Athletes Undergoing Surgery for Rare Vascular Condition
Findings from a comprehensive 20-year clinical study demonstrate treatment of functional popliteal artery entrapment syndrome (FPAES), particularly in combination with fasciotomy for exertional compartment syndrome, has shown highly effective outcomes, with 82% of patients returning to prior level of athletics.